Repligen RGEN Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Weighted Average Grant Date Fair Value
Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Weighted Average Grant Date Fair Value at other companies
Other financials
Where this comes from
Reported directly by Repligen in its filing.
Tagged under the XBRL concept us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue.
The official record: Repligen’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →
Ask your AI about Repligen's share based compensation arrangement by share based payment award equity instruments other than options vested in period weighted average grant date fair value.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Repligen's share based compensation arrangement by share based payment award equity instruments other than options vested in period weighted average grant date fair value?
- Repligen (RGEN) reported share based compensation arrangement by share based payment award equity instruments other than options vested in period weighted average grant date fair value of $155.80 in Q1 2026.
- What does share based compensation arrangement by share based payment award equity instruments other than options vested in period weighted average grant date fair value mean?
- This metric measures the average fair value at the time of grant for non-option equity awards that vested during the period. It provides insight into the cost basis of equity compensation granted to employees in prior periods. Investors use this to assess the historical valuation of equity incentives and their impact on total compensation expense.